Access to medical data for researchers has become a strategic lever to speed up health innovation, strengthen clinical research and develop artificial intelligence solutions in medicine. Yet collecting and using health data raises major challenges: regulatory compliance, personal data protection, dataset quality and system interoperability. In this context, specialised platforms like MAGE-X help reconcile scientific, legal and ethical requirements.
Why medical data matters for research
Researchers in epidemiology, biostatistics, medical data science and clinical research rely on structured, large-scale data to:
Sources of medical data for researchers include electronic health records, medico-administrative databases, disease registries, medical imaging and data from connected devices. Their value depends heavily on quality, completeness and traceability.
Regulatory framework: a non-negotiable requirement
In Europe, the use of health data is strictly governed by the GDPR, which classifies medical data as sensitive. In France, access to certain public databases requires CNIL authorisation and, for large research projects, specific procedures via the Health Data Hub.
Researchers must demonstrate:
Any strategy for accessing medical data for research must therefore embed these constraints from project design onwards.
Main challenges around medical data for researchers
1. Quality and heterogeneity
Data from multiple healthcare organisations is often heterogeneous (formats, nomenclatures, coding). Lack of normalisation can undermine scientific reproducibility.
2. Anonymisation and pseudonymisation
To comply with regulation, data must be processed to reduce re-identification risk. That requires robust methods suited to research use cases and data volumes.
3. Security and governance
Hosting health data implies high standards for cybersecurity, access traceability and usage governance.
4. Interoperability
Alignment with international standards (FHIR, HL7, SNOMED CT) is essential to support collaboration between research teams and institutions.
How MAGE-X supports access to medical data for researchers
MAGE-X acts as a technological and regulatory intermediary between data producers (hospitals, laboratories, research institutions) and end users (researchers, biotech, medtech, healthtech start-ups and industry). Its value rests on several pillars:
Data management and valorisation platform
MAGE-X provides infrastructure to centralise, structure and document medical datasets, supporting scientific use while maintaining a high level of compliance.
GDPR compliance and access governance
Integrated workflows support consent management, access traceability and documentation of research purposes—essential for any use of medical data by researchers.
Secured, compliant hosting
The platform relies on secure environments suited to health data hosting, reducing the risk of leaks or unauthorised access.
Interoperability and standardisation
MAGE-X helps align data with recognised standards, lowering the cost of dataset preparation for multicentre research projects.
Use cases: clinical research, medical AI and innovation
MAGE-X solutions address concrete needs:
Conclusion
Access to medical data for researchers is a key driver of scientific competitiveness and health innovation. Without suitable infrastructure, regulatory compliance and clear governance, research projects face significant legal and methodological risk. By combining technology, security and compliance, MAGE-X offers a structured way to turn unstructured health data into usable research assets while meeting the sector’s ethical and regulatory expectations.